Biocatalysis

News Biocatalysis

• Evocatal and RohnerChem announce strategic partnership for enzymatic chemistry development and upscaling

  Evocatal and RohnerChem combine their complementary services to offer customers a seamless solution for the development of high-performance biocatalytic processesand their rapid application in the synthesis of fine chemicals and API. The focus of this strategic partnership is to offer highly innovat more

• BASF is partner in the EU research project BIONEXGEN

  BASF is participating in the EU-supported research project BIONEXGEN (Next Generation of Biocatalysts). „BIONEXGEN brings together 17 partners from industry and academia who share the common goal of developing a new generation of biocatalysts for more sustainable production processes in the chemical more

• Almac continues biocatalysis business growth with a further $4m R&D investment

  The need for green, economic, robust and scaleable processes for the synthesis of chiral APIs and intermediates prompted Almacto build and fully integrate a biocatalysis group into its service portfolio. Last year Almac launched carbonyl reductase, transaminase, hydrolase, nitrilase, and nitrile hy more

White papers Biocatalysis

• Outsourcing R&D Innovation takes on New Meaning
  

  Innovative drugs are the lifeblood of pharmaceutical companies, but the cost of developing them is rising to unsustainable levels. Pharma executives are already saying that as the economy falters, they foresee bleak prospects and mergers unless their companies get more innovative drugs into their pipelines. The clock is ticking on the race to increase productivity, as key patents worth a projected $30 billion in revenue will expire between 2010 and 2013, opening the floodgates to competition from generics, according to Barbara Ryan, an analyst at Deutsche Bank. This imperative is propelling increased outsourcing of R&D operations as companies trim overcapacity. more

Publications Biocatalysis

• Design of β‐galactosidase/Silica Biocatalysts: Impact of the Enzyme Properties and Immobilization Pathways on their Catalytic Performance

  The use of heterogeneous biocatalysis in industrial applications is advantageous and the enzyme stability improvement is a continuous challenge. Therefore, we designed β‐galactosidase heterogeneous biocatalysts by immobilization, involving the support synthesis and enzyme selection (from Bacillus more

• Book review: Biocatalysis and Enzyme Technology

  Biocatalysis and Enzyme Technology – the second edition of this text book by Klaus Buchholz, Volker Kasche and Uwe Theo Bornscheuer is updated to provide the latest information in biocatalysis and enzyme technology. Book review by Mikhail Rabinovich. more

• Separation, Immobilization, and Biocatalytic Utilization of Proteins by a Supramolecular Membrane

  by Elisha Krieg, Shira Albeck, Haim Weissman, Eyal Shimoni, Boris Rybtchinski Membrane separation of biomolecules and their application in biocatalysis is becoming increasingly important for biotechnology, demanding the development of new biocompatible materials with novel properties. In the pres more

Market studies Biocatalysis

• Synthetech, Inc. (NZYM) - Financial and Strategic SWOT Analysis Review

  Synthetech, Inc. (Synthetech) is a publicly held pharmaceutical company specializing in organic synthesis, bio catalysis and chiral technologies. The company also develops and manufactures amino acid derivatives, specialty amino acids, peptide fragments, custom chiral intermediates for the pharmaceu more

Websites Biocatalysis